Cellectis S.A. American Depositary Shares
N/A
USD
N/A
N/A
...
Chart
Financials
Description
CLLS Company Description
Cellectis SA is a biotechnology company focused on developing immunotherapies for cancer. The company engages in gene editing in an attempt to lead the body's immune system toward attacking cancer cells. Cellectis utilizes strategic corporate partnerships along with cooperation through various university clinical centers. The company's gene-editing technologies allow for the creation of healthy cells derived from healthy donors rather than the patients themselves. It reports two segments: Therapeutics and Plants. Its Therapeutics segment focuses on novel cancer therapies, while its Plants segment focuses on agricultural biotechnology.
CLLS Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view CLLS Smart Score
Score Breakdown
CLLS Company Description
Show More
Cellectis SA is a biotechnology company focused on developing immunotherapies for cancer. The company engages in gene editing in an attempt to lead the body's immune system toward attacking cancer cells. Cellectis utilizes strategic corporate partnerships along with cooperation through various university clinical centers. The company's gene-editing technologies allow for the creation of healthy cells derived from healthy donors rather than the patients themselves. It reports two segments: Therapeutics and Plants. Its Therapeutics segment focuses on novel cancer therapies, while its Plants segment focuses on agricultural biotechnology. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of CLLS by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CLLS's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on CLLS's company Twitter account
WallStreetBets
Number of mentions of CLLS in WallStreetBets Daily Discussion
CLLS News
Recent insights relating to CLLS
CNBC Recommendations
Recent picks made for CLLS stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in CLLS
Corporate Flights
Flights by private jets registered to CLLS
Our Analysis